Yan Shu
- Oncology top 5%
- Pediatrics, Perinatology and Child Health top 5%
- Molecular Biology
- Pharmacology top 2%
- Health, Toxicology and Mutagenesis top 5%
- Co-authors
- Hong YangQing LiJames E. PolliKathleen M. GiacominiDong GuoShuzhong ZhangKatherine S. LovejoyStephen J. Lippard
- Topics
- Drug Transport and Resistance Mechanisms (20 papers)Pharmacological Effects and Toxicity Studies (11 papers)Pharmacogenetics and Drug Metabolism (7 papers)
- Cited by
- OncologyPharmacologyBiochemistry
- Partner nations
- United StatesChinaGermany
In The Last Decade
Yan Shu
30 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 114
- Oncology 626
- Pediatrics, Perinatology and Child Health 268
- Molecular Biology 263
- Pharmacology 165
- Health, Toxicology and Mutagenesis 161
Countries citing papers authored by Yan Shu
This map shows the geographic impact of Yan Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Shu more than expected).
Fields of papers citing papers by Yan Shu
This network shows the impact of papers produced by Yan Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Shu. The network helps show where Yan Shu may publish in the future.
Co-authorship network of co-authors of Yan Shu
This figure shows the co-authorship network connecting the top 25 collaborators of Yan Shu. A scholar is included among the top collaborators of Yan Shu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Shu. Yan Shu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 5 | |
| 3 | 18 | |
| 4 | 18 | |
| 5 | 2 | |
| 6 | 17 | |
| 7 | 25 | |
| 8 | 27 | |
| 9 | 19 | |
| 10 | 17 | |
| 11 | 20 | |
| 12 | 34 | |
| 13 | 71 | |
| 14 | 16 | |
| 15 | 42 | |
| 16 | 340 | |
| 17 | 4 | |
| 18 | 37 | |
| 19 | 16 | |
| 20 | Interindividual variations in levels and activities of cytochrome P-450 in liver microsomes of Chinese subjects. | 24 |
About Yan Shu
Yan Shu is a scholar working on Pharmacology, Oncology and Biochemistry, having authored 30 papers that have together received 1.2k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (20 papers), Pharmacological Effects and Toxicity Studies (11 papers) and Pharmacogenetics and Drug Metabolism (7 papers). The work is most often cited by research in Oncology (626 citations), Pharmacology (165 citations) and Biochemistry (100 citations). Yan Shu has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Hong Yang, Qing Li, James E. Polli, Kathleen M. Giacomini, Dong Guo, Shuzhong Zhang, Katherine S. Lovejoy, Stephen J. Lippard, Takafumi Komori and Joe W. Gray. Their work appears in journals such as Cancer Research, Pharmacological Reviews and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.